Medifast (MED) Tops Q1 EPS by 12c, Misses on Revenue

Medifast (NYSE: MED) reported Q1 EPS of ($0.07), $0.12 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $115.7 million versus the consensus estimate of $130.75 million.

GUIDANCE:

Medifast sees Q2 2025 revenue of $85-105 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• CLSA Upgrades Baozun (BZUN) to Outperform (2)
• Affirm Holdings (AFRM) Reiterated at Market Outperform by Citizens on Continued Upside